Indication for use
DoRSight™ is indicated for the transepithelial patterned application of riboflavin in the cornea prior to UV-A light irradiation with the C4V CHROMO4VIS™ device in theranostic-guided corneal cross-linking procedures.
Mode of use
DoRSight™ is interconnected to C4V CHROMO4VIS™ that powers it and checks its correct operation for the indication of use.
Technical specifications
- Current intensity between 0.5 mA and 2.0 mA.
- Application time between 5 min. and 10 min.
DoRSight™ enables fast and precise patterned delivery of riboflavin into the cornea with intact epithelium resulting in selective strengthening of corneal biomechanics and optical quality improvement with theranostic-guided corneal cross-linking procedures.
